Crew Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$499K Hold
3,499
– – 0.26% 76
2026
Q2
$548K Hold
3,499
– – 0.3% 70
2026
Q1
$534K Hold
3,499
– – 0.35% 70
2025
Q4
$482K Hold
3,499
– – 0.3% 73
2025
Q3
$449K Hold
3,499
– – 0.3% 73
2025
Q2
$423K Sell
3,499
-100
-3% -$11.3K 0.3% 78
2025
Q1
$401K Hold
3,599
– – 0.33% 92
2024
Q4
$350K Hold
3,599
– – 0.29% 99
2024
Q3
$414K Hold
3,599
– – 0.33% 86
2024
Q2
$383K Hold
3,599
– – 0.31% 86
2024
Q1
$348K Buy
3,599
+449
+14% +$46K 0.28% 88
2023
Q4
$318K Sell
3,150
-121
-4% -$11.7K 0.32% 62
2023
Q3
$333K Buy
3,271
+1
+0% +$102 0.36% 54
2023
Q2
$330K Hold
3,270
– – 0.38% 60
2023
Q1
$301K Hold
3,270
– – 0.43% 61
2022
Q4
$297K Hold
3,270
– – 0.43% 67
2022
Q3
$249K Hold
3,270
– – 0.34% 77
2022
Q2
$276K Hold
3,270
– – 0.35% 75
2022
Q1
$287K Hold
3,270
– – 0.28% 81
2021
Q4
$286K Hold
3,270
– – 0.24% 88
2021
Q3
$267K Hold
3,270
– – 0.25% 86
2021
Q2
$298K Hold
3,270
– – 0.28% 76
2021
Q1
$280K Buy
+3,270
New +$293K 0.28% 81

Other funds holding NVS

Crew Capital Management's NVS Position: Q3 2026 in Review

Crew Capital Management held its Novartis (NVS) position steady in Q3 2026 at 3,499 shares worth $499K. The position accounts for 0.26% of the portfolio, ranked #76.

Crew Capital Management first reported a position in NVS in Q1 2021 and has held it in 23 quarters since. The position peaked at $548K in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Crew Capital Management held 3,499 shares of Novartis worth $499K as of Q3 2026.
  • Crew Capital Management left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.26% of Crew Capital Management's portfolio in Q3 2026, its #76 holding.
  • Crew Capital Management first reported a position in Novartis in Q1 2021 and has held it in 23 quarters since.
  • Crew Capital Management's Novartis position peaked at $548K in Q2 2026.
  • 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Crew Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.